Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- PyreneesIndependent statistical analysis of Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.: Complete Statistical AnalysisIndependent statistical analysis of QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- QDOT-FASTIndependent statistical analysis of Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation.: primary…
- QE3Independent statistical analysis of Effects of Coenzyme Q10 (CoQ) in Parkinson Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00740714).
- Qingdao: Insulin Pump Follow-Up Program: Complete Statistical AnalysisIndependent statistical analysis of Qingdao: Insulin Pump Follow-Up Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02655666).
- QL vs PENG for Analgesia After Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of QL vs PENG for Analgesia After Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05710107).
- QP ExCELsIndependent statistical analysis of Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- QSINDIndependent statistical analysis of Topical Irrigation Therapy for CRS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02630472).
- Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03408483).
- QUALIFY IPFIndependent statistical analysis of Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266): Complete Statistical AnalysisIndependent statistical analysis of Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Quality of Recovery After Reversal With Neostigmine or Sugammadex.: Complete Statistical AnalysisIndependent statistical analysis of Quality of Recovery After Reversal With Neostigmine or Sugammadex.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02909439).
- Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- QUANTIFYIndependent statistical analysis of The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study: Complete Statistical AnalysisIndependent statistical analysis of Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- QUARTO_IIIIndependent statistical analysis of Quartet Lead and Resynchronization Therapy Options III (QUARTO_III): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02476201).
- QUASARIndependent statistical analysis of A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced…
- QuercetinIndependent statistical analysis of Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01708278).
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: Complete Statistical AnalysisIndependent statistical analysis of Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.: Complete Statistical AnalysisIndependent statistical analysis of Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD): Complete Statistical AnalysisIndependent statistical analysis of Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- QuickOpt Chronic Study: Complete Statistical AnalysisIndependent statistical analysis of QuickOpt Chronic Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01172067).
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02383498).
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy: primary endpoint results, effect estimate with confidence interval,…
- QUINCEIndependent statistical analysis of Ophthalmic Compatibility During Seven Days of Continuous Wear of Silicone Hydrogel Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- QUIPSIndependent statistical analysis of Quality Improvement and Personalization for Statins: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02820870).
- QUITIndependent statistical analysis of A Pilot Randomized Controlled Trial of Financial Incentives, Text Messaging, and Usual Care for Homeless Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Quit or Switch: E-cigarette Study: Complete Statistical AnalysisIndependent statistical analysis of Quit or Switch: E-cigarette Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05525078).
- QuitBet Phase II: A Digital Social Game That Pays You to Stop Smoking: Complete Statistical AnalysisIndependent statistical analysis of QuitBet Phase II: A Digital Social Game That Pays You to Stop Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- QUORUMIndependent statistical analysis of Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- QureIndependent statistical analysis of The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01318356).
- QWINT-1Independent statistical analysis of A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1): primary…
- QWINT-2Independent statistical analysis of A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time: primary endpoint results,…
- R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- R-DISSOLVEIndependent statistical analysis of An Exploratory stuDy of effectIveneSs and Safety of rivarOxaban in Patients With Left VEntricular Thrombus (R-DISSOLVE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- R2D2Independent statistical analysis of Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RA-BRANCHIndependent statistical analysis of A Study of Baricitinib in Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04086745).
- RAAS and Arterial Stiffness in SCI: Complete Statistical AnalysisIndependent statistical analysis of RAAS and Arterial Stiffness in SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04510974).
- RADIndependent statistical analysis of Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients: primary endpoint results, effect estimate with confidence…
- RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment: Complete Statistical AnalysisIndependent statistical analysis of RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RAD001 Plus Bevacizumab in Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of RAD001 Plus Bevacizumab in Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00591734).
- RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RAD1801Independent statistical analysis of RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RADARIndependent statistical analysis of Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00538759).
- RADIANCYIndependent statistical analysis of Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access: primary endpoint results, effect estimate…